Ophthalmology

Latest News

bevacizumab biosimilars and retinopathy of prematurity | Image credit: Photographee.eu - stock.adobe.com
Biosimilar Bevacizumab Matches Avastin in Treating Retinopathy of Prematurity

October 14th 2025

A new study reveals Stivant, a bevacizumab biosimilar, matches Avastin in safety and efficacy for treating retinopathy of prematurity in infants.

FDA approves Celltrion aflibercept biosimilar | Image credit: Tada Images - stock.adobe.com
FDA Approves Celltrion Aflibercept Biosimilar: Eydenzelt

October 13th 2025

Eye health and biosimilars | Image credit: 61766578 - stock.adobe.com
Real-World Stability Confirmed for Biosimilar Ximluci in Prefilled Syringes

October 9th 2025

aflibercept biosimilars produce safe and effective results for patients with nAMD | Image credit: Coetzee/peopleimages.com - stock.adobe.com
Proposed Aflibercept Biosimilar Shows Comparable Safety, Efficacy in Phase 3 AMD Trial

October 2nd 2025

eye computer | Image credit: eevl - stock.adobe.com
Global Aflibercept Biosimilar Progress Signals Rising Access for Retinal Disease Care

September 22nd 2025

More News

© 2025 MJH Life Sciences

All rights reserved.